Yes, she walked out of her party who muffled her... deniers of Freedom of Speech. Ever heard of that traitors?
The Vigilant Fox 🦊
@VigilantFox
HUGE: Renowned feminist and ex-Clinton advisor endorses Donald Trump for president!

“The people I voted for silenced my voice. They killed thousands of people and put the man [Steve Bannon] who tried to help me save the lives of thousands of people in prison. And at a certain point, you just have to stand up for what's right,” @naomirwolf
told Bannon.

Her reasons for voting for Trump are because she:

• Was silenced by Biden-Harris regime for warning about the dangers of the COVID mRNA injections and opposes censorship.

• Sees Trump as an “eloquent, articulate, thoughtful, and very funny” leader.

• Supports Trump's efforts for peace in the Middle East.

• When Democrats shut her down and infringed on her First Amendment rights, it was Steve Bannon and the War Room posse who offered to lift up her voice.

Wanted to take a starter here but Fidelity would not take the order.

I don't know!! But check this out >>> https://www.neom.com/en-us/newsroom/neom-establishes-sar-700-million-concrete-factory-for-the-line

"As an advanced concrete production facility, the factory’s plants will incorporate carbon capture and utilization (CCU) technology and energy-saving solutions, with majority of output servicing the construction of THE LINE. With concrete being a core material for THE LINE’s substructure and superstructure, the new factory has mobilized a fleet of support vehicles in readiness for operations to commence next month. Peak operations are anticipated to start in 2025, and the facility is expected to generate over 500 local jobs."

Could it be? If so, Kattie bar the door. Let it trap some smelly shorts.

I used to think the constant PR updates on tech achievements would eventually translate into an increasing PPS.
Boy was I wrong on this one. I get a most of them right, and this may eventually pay off. Right now it sucks and
guess what, they never talk about the slumping pps. Only we get they are so happy for investor support. I guess so.
I'll buy more when a real turnaround is confirmed. Not bullish nor bearish just pissedish.

Bullseye!

"NO rationalism or hard facts will make them change, they are paid to do a job, and that's it!"
Added to my follow list. Great to have your experience here.

Yes, green in 3 accounts is fun to watch. Sorry you didn't get in earlier and showed up when red lights about your shorts went flashing.
Longs know what is going on and you guys are scared ....less.

CytoDyn’s purpose is to help enhance the lives of patients with life-threatening diseases. Our mission is to alleviate human suffering and improve patients' quality of life through innovation and collaboration. We are committed to performing our duties with respect, integrity, and a unified vision of serving humanity.

CytoDyn is a clinical stage biotechnology company developing innovative treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Leronlimab is being studied for oncology and inflammation, as well as other potential indications, including but not limited to HIV and MASH. Leronlimab is a competitive rather than allosteric inhibitor of the CCR5 receptor. We believe this mechanism of action, of binding competitively to the CCR5 receptor, differentiates leronlimab from all other CCR5 antagonists.

This competitive inhibitor is key to saving life is the the key to riches! Good job CEO Dr. J and COB Tanya....who by the way didn't get any more shares more than the others and less than the CEO. So far, turning around this company has been job #1 and what a good job thus far. $CYDY$ 2024

Oh and look what was added to the skeleton crew just lately:

CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC Laboratories
Oct 30, 2024 8:30am EDT
CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development
Oct 08, 2024 8:30am EDT

Shorts are working overtime again to keep the pps from ascending too quickly aided by MM's buying for clients of clout piecemeal so as not to attract attention. How fun this is going to be to watch once the buy-to-cover trades start. TIK TOK is the speed of the clock. Watch.
Weekend action?? I love em.

LOLOLOL which assay company you say is fraudulent? I can't hear you.

Read about the Taber option. This has got my blood churning. If you have not checked out the web site, you are in for a surprise to it's content and quality!!
https://northbay-resources.com/

Long Horn Bull digging in. May not even sell for a few years!

Don't forget this. With the Rhodium, palladium, platinum values from assays that add value so much that it is like doubling our gold value alone.
And that does not include the silver. Only thing rosier is Rose Gold... a bit of copper in the gold turns it rosey.
Speaking of rosey. Copper up .4% today. And let's not forget about our copper/gold etc up in BC and the olivine.
This is going to be a ball buster mining company for shorts. Many have not covered yet as witnessed by their chirping when prices move up.
How fun this will be to watch. No hurry, it's coming!!

No... that's your failure not ours. $NBRI$

Exactly... well said, "Quick to sling mud slow to do DD".
Hit u up as well.

Back in the green. Good company with a great product and huge demand building.

Investors are the most impatient lot almost like kids going to the State Fair. Way too antsy.
All things come in due order and due process in due time.

Use the down time to add should your own due diligence point you correctly.
Think too, every increase in metal prices means less quality of material is profitable.
And think of it, we are sitting on a pile of good stuff while the shorts are sitting on a pile of ....

Sit back and relax. Time flies way to quickly.

Moose Hockey and full of it.

Odds are there is going to be a nice assay report. From my personal experience, it can take a few weeks to get back a report from assay labs. But today, with the gold rush ongoing you will be waiting in line for your lab results.

Here are some almost current metal prices. And we have more than gold. Some of these use methods other than fire assay and can take awhile to be
processed.

Metal Price (USD) Date
Aluminum $ 1.1884 lb 10/31
Cobalt $ 11.022 lb 10/30
Copper $ 4.3152 lb 10/31
Gold $ 2739.46 oz 10/31
Iron Ore $ 104.08 mt 10/30
Lead $ 0.9251 lb 10/31
Molybdenum $ 30.438 lb 10/31
Neodymium $ 2.3057 oz 10/31
Nickel $ 7.1361 lb 10/31
Palladium $ 1106.00 oz 10/31
Platinum $ 990.90 oz 10/31
Rhodium $ 4675.00 oz 10/31
Silver $ 32.665 oz 10/31
Tellurium $ 99.779 kg 10/31
Tin $ 14.039 lb 10/30
Uranium $ 80.100 lb 10/30
Zinc $ 1.3733 lb 10/31

Will be adding some more.

Ah there's gold in them thar hills. Just sally on down to ole Jared and ask if you can borrow a pan.
Yep, then come back and say, no gold today. There is plenty of gold.

Yes sir that's what happens. Stock in lieu of salary during development phase saves cash while providing incentive to focus on the future as trials getting put in place. The new team member is going to be quite helpful with all his experience. I am excited seeing these developments. Good job Tanya is doing with Dr. Jay in this regard. Go Cytodyn. Good job TEAM LERONLIMAB. Bringing leronlimab to the millions of patients who deserve the best. $CYDY$ 2024 Go baby go.

CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC Laboratories
Oct 30, 2024 8:30am EDT
"An internationally renowned hepatologist, Dr. Palmer brings more than three decades of deep research experience to the CytoDyn team. She has held leadership positions at several biotech and pharmaceutical companies, including serving as Chief Medical Officer of Gannex/Ascletis and Head of Liver Disease at Takeda Pharmaceutical Company. She has also worked as a hepatology consultant with over 60 biotech and pharmaceutical companies since 1991 and previously served as interim Chief Medical Officer of CytoDyn.

In addition to consulting, Dr. Palmer has been the primary investigator for numerous clinical trials in MASH and other liver diseases. Her work has been published in over 100 publications, abstracts, manuscripts, books and book chapters, including several guidelines she co-authored with colleagues from the FDA and EMA concerning drug-induced liver injury among patients in clinical trials evaluating potential drugs to treat MASH and other liver diseases. She also maintained a solo medical practice treating patients with liver disease for over 20 years."

CytoDyn Appoints Dr. Max Lataillade as Senior Vice President and Head of Clinical Development
Oct 08, 2024 8:30am EDT


CytoDyn Announces Abstract that Highlights Leronlimab’s Potential in Mediating ART-Free Viral Control in Infant Rhesus Macaques
Oct 07, 2024 11:05am EDT

CytoDyn Engages Syneos Health as CRO For Its Phase II Oncology Trial
Oct 04, 2024 8:30am EDT

CytoDyn Announces Preliminary Findings in Study with SMC Laboratories
Sep 24, 2024 8:30am EDT

September 2024 Letter to Shareholders
Sep 09, 2024 8:30am EDT

Way oversold, personnel in place and equipment ready willing and able, buyers who buy when blood is in the streets(literally!!!), drill baby drill attitude incoming, dwindling supply and competition, increasing tension on political front.... count down 5 more days.....

All IMA (assessments) and why I am a buyer. The war has pushed the greenie weenies out the back door. Enter a refocused O&G era. Israel is not about to
pass up the chance to be a producer of carbon.

Raadr, Inc. CFO Invited for Interview on the Floor of the NYSE
Raadr, Inc.
October 24, 2024 https://finance.yahoo.com/news/raadr-inc-cfo-invited-interview-120000395.html

I think I will add to my little starter. This could be something big. You don't get invited to be interviewed on the floor of the largest exchange for nothing.

PHOENIX, AZ / ACCESSWIRE / May 15, 2024 / RAADR, Inc. (OTC PINK:RDAR) a technology and development company that provides cutting edge software solutions to detect and combat cyber-bullying and cyber-harassment throughout the internet on social media platforms is pleased to announce that it has been officially approved for Trademark rights on its name and logo on May 7th , 2024 by the United States Patent and Trademark office.

RAADR's Trademark registration number is 7378628. The Trademark consists of a shape of concentric circles with an arrow pointing to the third circle. The stylized wording "RAADR" in bold capital letters is on the right side of the concentric circles and can be found at the link below:

Interesting stock. NEW YORK, NY / ACCESSWIRE / October 18, 2024 / Raadr, Inc. (OTC Pink:RDAR) ("Raadr" or the "Company") is pleased to announce that it has reached a definitive agreement with certain shareholders for the cancellation of 1.7 billion common shares. This strategic decision reflects the Company's commitment to enhancing shareholder value by optimizing its capital structure. In addition, Raadr has opted not to pursue a reverse stock split at this time. The Company believes that the current capital structure provides significant potential for unlocking shareholder value, positioning Raadr for future growth without the need for such a measure.

So the companies who do assays for prospectors and miners are fraudulent?
How long have you been investing in the mining sector?
How obvious these shorts and flippers.

Driving the adit and no need of stopes... how sweet it this!!
Let's go down the shaft and have a look see in the adit and follow the drift.
OMG here tis.... with the less costs for placer extraction going horizontal along the deposit following the channel and with these high grade assays, it is why investors are getting really excited. Many Jr. Miners are now boasting of huge gold assays with less than half of what North Bay is showing!!! Should be getting some updates reasonably soon.
Mt. Vernon Assays - October 2024
Sample I.D.
Location


Gold Silver Platinum Palladium Rhodium
oz/ton oz/ton oz/ton oz/ton oz/ton

2021263288
Right Cross Cut L
3.29
0.37
1.23
0.02
N.D.
2021263224
Right Cross Cut R
3.39
0.36
0.91
0.47
0.16
2021263294
3+90-4+00 L
1.17
0.32
0.66
0.02
N.D.
2021263225
4+30-4+40 L
1.63
0.38
1.29
0.32
0.33
2021263223
4+40-4+50 L
4.92
0.39
1.15
0.02
N.D.
2021263226
4+50-4+60 L
5.02
0.48
1.49
0.25
0.45
2021263222
4+70-4+80 L
4.01
0.48
1.44
0.14
N.D.
2021263227
3+90-4+00 R
2.17
0.67
1.34
0.16
N.D.
2021263221
4+10-4+20 R
3.71
0.31
1.03
0.16
0.21
2021263220
4+20-4+30 R
3.00
0.67
1.28
0.42
0.26
2021263291
4+40-4+50 R
1.28
0.33
1.15
0.32
N.D.
2021263289
5+10-5+20 R
0.69
0.70
1.30
0.45
0.29

You are full of it. Here is your candidate loverboy. https://forbiddennews.substack.com/p/vp-candidate-tim-walz-child-rape?publication_id=1658626&post_id=150291690&triggerShare=true&isFreemail=true&r=3uchee&triedRedirect=true

Yep Doc, let's point it out again!! CytoDyn Appoints Dr. Melissa Palmer, M.D., as Lead Consultant in Hepatology; Announces Follow-Up Inflammation Studies with SMC Laboratories
GlobeNewswire (Is it sinking in yet pigeons?)
41 mins ago

VANCOUVER, Wash., Oct. 30, 2024 (GLOBE NEWSWIRE) -- CytoDyn Inc. (CYDY.NaE) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Dr. Melissa Palmer, M.D., has been engaged as Lead Consultant in Hepatology. In this role, Dr. Palmer will drive the Company’s strategy for research and development in Hepatology, leveraging her expertise to further CytoDyn’s clinical evaluation of leronlimab in treating liver conditions, including MASH and liver fibrosis. This engagement follows the recent breakthroughs with SMC Laboratories (“SMC”).

In addition, the Company announced that following promising initial results from its preclinical study with SMC, it has commissioned the lab to conduct two follow-up studies to confirm and extend the observation of fibrosis reversal observed in the study concluded in September 2024. Both follow-up studies are underway, with results expected in early 2025.

An internationally renowned hepatologist, Dr. Palmer brings more than three decades of deep research experience to the CytoDyn (CYDY.NaE) team. She has held leadership positions at several biotech and pharmaceutical companies, including serving as Chief Medical Officer of Gannex/Ascletis and Head of Liver Disease at Takeda Pharmaceutical Company. She has also worked as a hepatology consultant with over 60 biotech and pharmaceutical companies since 1991 and previously served as interim Chief Medical Officer of CytoDyn (CYDY.NaE).

In addition to consulting, Dr. Palmer has been the primary investigator for numerous clinical trials in MASH and other liver diseases. Her work has been published in over 100 publications, abstracts, manuscripts, books and book chapters, including several guidelines she co-authored with colleagues from the FDA and EMA concerning drug-induced liver injury among patients in clinical trials evaluating potential drugs to treat MASH and other liver diseases. She also maintained a solo medical practice treating patients with liver disease for over 20 years.

Thanks for the cheapies pigeons!!! $$$CYDY$$$ 2024-25 Atta boy Dr. Jay!! You got it, take it away! 😍

Gold 2,791.00 +9.90 (+0.36%)

https://childrenshealthdefense.org/defender/idaho-health-board-defy-cdc-fda-covid-vaccines-clinics/?utm_id=20241029

the reasons to keep shorting this scam company keeps mounting weekly.
Just the beginning .....

Imagine how deep this will go into the tube when Kennedy runs the show. All these killer drugs will be re-assessed. Going to be some real
long overdue house cleaning. Pig Pharma brought it on themselves. Now time is approaching to pay the piper.

Going short on next push up. Again.

Know it well, Gunny man here. Love that idea for Barndominiom. Stayed in one years ago up in N. California Yreka during a basketball tournament.
It was way cool and way big. A good friend of mine I went to visit in Iowa had a huge barn built by his grandfather and neighbors. He converted it to
a party barn. It was amazing.
Congrats on the making it 25 years!!! Hats off to you bigly.

Movano trading halt lifted and resuming. Up to 4.48 now
When done for the right reasons a RS can work as it was originally intended to do.
Since it is not a scam and they needed to comply, and are on the verge of FDA
approval(hopefully) fairly soon, it seems investors are bullish thus far.
I missed this play this morning for some quick profit. Can't watch em all.

I think Movano will do ok.

Had a couple orders filled but one was bypassed having gone lower. Last time this happened the stock went on a run. These MM's are working for some bigger clients. There were a few nice sized buys. Perhaps some news is coming. Who knows?
$CYDY$ 2024
When the pigeons start gathering and begin their chirping, I get ready to add.

Are you in Boise? I was there for a couple years and in Moscow for a summer. Can't recall the area that we found a little gold, but nothing like your showings.
Would love to get out again and do more prospecting. On another outing we did a little drilling ... i think it was on Yankee Fork near Sunbeam. I remember an old dredge still sitting in the river. East of that maybe it was Silver Creek. We were looking for the placer source for that dredge. My cousin who was a mining engineer was working up there in the summer for the USGS surveying while going to the Colorado School of Mines. He later went on to Africa were he lived for 20 years and located a huge tin placer. He died over there too of some strange disease back around 2005. I miss Idaho. A great state that I hope gets a bit bigger...hello Eastern Oregon!

The era of good feelings and hope is about to return in a few more days. Get ready scammers for a reality check.
Amazing this song... when I clicked on your post... it was playing on my Bose!! The timing is right for many things.
$NBRI$

I surveyed and staked hundreds and hundreds of claims for Homestake and others .... all on BLM
and National Forests. A few I would love to have the time to go back to and check out with my high banker.
Many an uplifted ancient river bed was bypassed. Jared didn't pass this baby up. He knew he had to
get that mill cranked up. $NBRI$ Lucky to be here. Thank you Lord!!

The only scammers here are those squealing like stuck pigs. The rest of us are making money
and set up to make lots more. I bought more today.
When the squealers come together in harmony, they sing one song beautiful to my ears...

That could be MASSIVE. AT last count this is one stock out of 214 in my portfolio. So very few do I post about.
Without a doubt this company I rate in my top 5. This IQSTEL has their ducks in a row sin duda.
Take it away Johnie Canales. You got it.

The hole keeps getting wider and deeper. https://childrenshealthdefense.org/defender/pfizer-moderna-mrna-covid-shots-acute-heart-disease-risk/?utm_id=20241028

Ready for some more?

Don't know when but I predict another big run. Legal junk aside and off to the races we go. Just got that feeling.

Bill Gates ain't laughin... Bill Gates Humbled Like Pie As.....Bill Gates Humbled Like Pie As 'Vax' Trial Draws Near Fast: November 27, 2024 | Yes, ‘Even if … your name is Bill Gates, you still have to go to court’
Not only is there a Nuremberg Hearing in Costa Rica starting November 11 about Gates and his vax peddler cohorts, but huge BOOM, Netherlands Judge Rules Covid Vaccine Lawsuit Can Proceed November 27!
Interest of Justice
Oct 28, 2024
https://interestofjustice.substack.com/p/bill-gates-humbled-like-pie-as-vax?publication_id=825071&post_id=150615739&isFreemail=true&r=47wykb&triedRedirect=true

Anyone who was injured or had family and friends who died or are currently suffering from the numerous secondary affects of the jab, should read this so send it out.